STEVENS CAPITAL MANAGEMENT LP

Position in JNJ — Johnson & Johnson

CIK 1134813 RADNOR, PA

Position in JNJ

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$763,687

+$525,902 QoQ

Shares Held

3,007

+161.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#3,268

of 4,664 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STEVENS CAPITAL MANAGEMENT LP holds $7,554,742 across 5 Drug Manufacturers - General names. JNJ ranks #4 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,749	$3,297,233
2	PFE	Pfizer Inc	85,193	$2,051,447
3	GILD	Gilead Sciences, Inc.	6,346	$801,753
4	JNJ	Johnson & Johnson This page	3,007	$763,687
5	NVO	Novo Nordisk A S	13,363	$640,622

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$763,687	3,007	+161.7%	Shares	Sole	2026-08-11
2025-12-31	$237,785	1,149	-93.6%	Shares	Sole	2026-02-03
2025-09-30	$3,308,078	17,841	+43.4%	Shares	Sole	2025-11-10
2025-06-30	$1,900,668	12,443	+25.5%	Shares	Sole	2025-08-12
2024-12-31	$1,433,762	9,914	+361.3%	Shares	Sole	2025-02-11
2023-06-30	$355,702	2,149	-42.5%	Shares	Sole	2023-08-14
2023-03-31	$579,235	3,737	+211.9%	Shares	Sole	2023-05-12
2021-12-31	$204,941	1,198	-93.0%	Shares	Sole	2022-01-28
2021-09-30	$2,782,483	17,229	+39.8%	Shares	Sole	2021-11-12
2021-06-30	$2,029,596	12,320	+87.9%	Shares	Sole	2021-08-12
2021-03-31	$1,077,642	6,557	-90.9%	Shares	Sole	2021-05-11
2020-06-30	$10,132,391	72,050	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.